Saturday 17 October 2026 Export ARQT’s income statement to Excel — free account

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024. In the quarter to June 2026, revenue grew 59.3%, EPS grew 184.6%, free cash flow grew 228.0% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

28.82 0.28 −0.96%

Follow ARQT

Alert me

Market cap: $3.7B
P/E: 131×
Fwd P/E: 196×
Dividend yield: —
F-score: 4/9
Altman Z: 6.98
Beneish M: −1.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	119.18
P/S ratio Full definition →		7.57	9.82	7.33	7.38
P/FCF ratio Full definition →		0.00	0.00	269.53	142.16
P/Operating CF Full definition →		(1,371.55)	141.11	1,361.25	270.77
P/B ratio Full definition →		15.22	19.50	16.07	15.52
Price to Tangible BV Full definition →		16.86	21.15	17.38	16.54
EV/Sales Full definition →		7.31	9.53	7.06	7.10
EV/EBITDA Full definition →		0.00	0.00	724.90	92.59
EV/Operating CF Full definition →		(71.34)	(636.90)	108.65	83.76
EV/FCF Full definition →		(48.15)	(168.11)	259.37	136.76
Quick Ratio Full definition →		3.07	2.83	2.26	2.46
Current Ratio Full definition →		3.50	3.17	2.68	2.92
Net Debt/EBITDA Full definition →		(9.71)	(5.92)	13.19	(7.75)
Debt/Assets Full definition →		29.25%	25.17%	23.79%	22.29%
Debt/Equity Full definition →		0.69	0.58	0.58	0.49
Asset Turnover Full definition →		0.79	0.96	1.03	1.10
Operating CF/Net income Full definition →		(0.24)	1.51	(0.20)	0.84
Capex/Depreciation Full definition →		0.00	0.00	0.00	(0.46)
Interest Coverage Full definition →		2.78	6.13	(2.08)	4.82
Research and Development Expense of Revenue Full definition →		19.76%	15.79%	29.06%	15.67%
Selling, General and Administrative Expense of Revenue Full definition →		62.90%	60.98%	70.28%	63.25%
Intangible Assets out of Total Assets Full definition →		0.04	0.03	0.03	0.03
Share Based Compensation of Revenue Full definition →		10.12%	7.77%	10.14%	9.83%
Graham Net Nets Full definition →		0.06	0.05	0.06	0.06
Graham Number Full definition →		0.00	0.00	0.00	2.89
Earnings Yield Full definition →		(1.91%)	(0.45%)	(0.08%)	0.84%
Free Cash Flow Yield Full definition →		(2.01%)	(0.58%)	0.37%	0.70%
Revenue per Share Full definition →		0.78	1.02	0.81	0.99
Operating CF per Share Full definition →		(0.01)	0.21	0.02	0.10
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.01)	0.21	0.02	0.10
Cash per Share Full definition →		1.50	1.74	1.73	1.83
Shareholders Equity per Share Full definition →		1.24	1.49	1.47	1.69
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		1.24	1.49	1.47	1.69
Free Cash Flow Full definition →		(1.75)	26.19	2.24	12.48
Working Capital Full definition →		249.45	281.39	274.85	307.33
Capital Expenditures Full definition →		0.00	0.00	—	(0.16)
Net Current Asset Value Full definition →		136.32	167.74	167.70	199.71
EV/EBIT Full definition →		0.00	0.00	912.84	96.12
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	948.60	99.91
Other line items
Average Receivables Full definition →		87.62	109.65	114.90	130.93
Average Payables Full definition →		12.56	13.37	21.41	10.84
Average Inventory Full definition →		18.22	18.58	27.00	27.60
Average Assets Full definition →		404.17	390.93	402.05	420.49
Average Common Equity Full definition →		157.36	173.51	166.15	179.78

Fold the line items

Columns are period end dates

Stockrow Weekly